306 COMPARISON OF A RESTRICTIVE VERSUS LIBERAL RED BLOOD CELL TRANSFUSION POLICY IN MYELODYSPLASTIC SYNDROMES AND OTHER BONE MARROW FAILURE DISORDERS – A SYSTEMATIC REVIEW
Yisu Gu(University of Oxford), Paresh Vyas(University of Oxford), Carolyn Dorée(NHS Blood and Transplant), Lise J Estcourt(NHS Blood and Transplant), Sally Hopewell(University of Oxford), Marialena Trivella(University of Oxford)
Cited by 1
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k